These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 16465821

  • 1. [Management of cutaneous leishmaniasis in adults and children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 3. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H, Sharma KK, Rijal S, Dwivedi S, Koirala S.
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R, Handjani F, Nouhpisheh MK.
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P, Pezeshkpoor F, Soruri AH, Naviafar P, Moghiman T.
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [Abstract] [Full Text] [Related]

  • 6. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ.
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [Abstract] [Full Text] [Related]

  • 7. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
    Solomon M, Pavlotsky F, Leshem E, Ephros M, Trau H, Schwartz E.
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
    [Abstract] [Full Text] [Related]

  • 8. Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
    Sridharan K, Sivaramakrishnan G.
    Acta Trop; 2021 Aug; 220():105944. PubMed ID: 33957088
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A.
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [Abstract] [Full Text] [Related]

  • 10. Miltefosine for new world cutaneous leishmaniasis.
    Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H.
    Clin Infect Dis; 2004 May 01; 38(9):1266-72. PubMed ID: 15127339
    [Abstract] [Full Text] [Related]

  • 11. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec 01; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 12. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M, Anwar AE.
    J Eur Acad Dermatol Venereol; 2010 Mar 01; 24(3):335-40. PubMed ID: 19744259
    [Abstract] [Full Text] [Related]

  • 13. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions.
    Couppié P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R.
    Am J Trop Med Hyg; 2004 Nov 01; 71(5):558-60. PubMed ID: 15569784
    [Abstract] [Full Text] [Related]

  • 14. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Nov 01; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G, Nilfroushzadeh MA, Iraji F.
    Clin Exp Dermatol; 2007 Jul 01; 32(4):371-4. PubMed ID: 17376205
    [Abstract] [Full Text] [Related]

  • 16. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB, Das P.
    Am J Trop Med Hyg; 2009 Mar 01; 80(3):336-8. PubMed ID: 19270277
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ.
    Am J Trop Med Hyg; 2007 Oct 01; 77(4):640-6. PubMed ID: 17978064
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P, Yazdanpanah MJ, Vosugh EM, Pezeshkpoor F, Shakeri MT, Moghiman T.
    Am J Trop Med Hyg; 2007 Jul 01; 77(1):99-101. PubMed ID: 17620637
    [Abstract] [Full Text] [Related]

  • 19. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA, Jaffary F, Ansari N, Siadat AH, Nilforoushan Z, Firouz A.
    J Vector Borne Dis; 2008 Dec 01; 45(4):287-91. PubMed ID: 19248655
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.
    Firdous R, Yasinzai M, Ranja K.
    Int J Dermatol; 2009 Jul 01; 48(7):758-62. PubMed ID: 19570087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.